Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-013294
Filing Date
2023-04-18
Accepted
2023-04-18 16:30:48
Documents
7
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A acet-def_14a-2023.htm DEF 14A 1268009
2 GRAPHIC img135988676_0.jpg GRAPHIC 3411
3 GRAPHIC img135988676_1.jpg GRAPHIC 3411
4 GRAPHIC img135988676_2.jpg GRAPHIC 72591
5 GRAPHIC img135988676_3.jpg GRAPHIC 89028
6 GRAPHIC img135988676_4.jpg GRAPHIC 18310
7 GRAPHIC img135988676_5.jpg GRAPHIC 93742
  Complete submission text file 0000950170-23-013294.txt   1656157
Mailing Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38359 | Film No.: 23827202
SIC: 2834 Pharmaceutical Preparations